Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Jun 9, 2012
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
Patients who received surveillance endoscopy for EGC using a zoom endoscope were eligible for inclusion. WLE without magnification was performed first in eligible patients. Based on an assessment of the shape (such as flat, depressed or elevated) and color (pale or reddened), small focal gastric lesions were identified and included for evaluation by experienced endoscopists. When such a lesion was detected during non-magnifying observation with WLE, the mode was then changed to ME-NBI for observation of microvascular pattern and ME-AIM for observation of microsurface pattern subsequently. A...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients, in which small focal gastric lesions were identified with conventional WLE, were enrolled in this study. Before being enrolled, all patients provided written informed consent.
- Exclusion Criteria:
- • Patients who cannot undergo gastroscopies due to unsuitable conditions
- • Referred patients with a history of having being diagnosed as gastric cancer
- • Patients with a personal history of gastric surgery
- • Patients who cannot provide informed consent
- • Patients with advanced gastric cancer
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Xinghua Lu, Dr
Principal Investigator
Peking Union Medical College Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials